Windlas Biotech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 215.33 | 207.65 | 198.75 |
Operating Expense | 183.57 | 177.16 | 170.38 |
Net Profit | 17.67 | 16.29 | 15.23 |
Net Profit Margin | 8.21 | 7.84 | 7.66 |
Earning Per Share | 8.43 | 7.77 | 7.29 |
EBIDTA | 31.73 | 30.57 | 27.55 |
Effective Tax Rate | 17.47 | 15.12 | 13.82 |
Particulars | Jun 2025 |
---|---|
Revenue | 215.33 |
Operating Expense | 183.57 |
Net Profit | 17.67 |
Net Profit Margin | 8.21 |
Earning Per Share | 8.43 |
EBIDTA | 31.73 |
Effective Tax Rate | 17.47 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 759.88 | 630.96 | 513.08 |
Operating Expenses Annual | 665.76 | 552.85 | 452.84 |
Operating Profit Annual | 111.76 | 91.57 | 70.21 |
Interest Annual | 4.38 | 1.10 | 0.79 |
Depreciation | 26.88 | 13.20 | 12.17 |
Net Profit Annual | 60.65 | 58.14 | 42.64 |
Tax Annual | 18.75 | 18.88 | 14.41 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 759.88 |
Operating Expenses Annual | 665.76 |
Operating Profit Annual | 111.76 |
Interest Annual | 4.38 |
Depreciation | 26.88 |
Net Profit Annual | 60.65 |
Tax Annual | 18.75 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 5.24 | 3.69 | 0.55 |
Cash Flow from Operations | 68.23 | 108.91 | 60.98 |
Cash Flow from Investing | -74.06 | -92.07 | -14.11 |
Cash Flow from Financing | 1.01 | -15.29 | -43.74 |
Cash Flow at the End | 0.42 | 5.24 | 3.69 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 5.24 |
Cash Flow from Operations | 68.23 |
Cash Flow from Investing | -74.06 |
Cash Flow from Financing | 1.01 |
Cash Flow at the End | 0.42 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 14.71 | 14.51 | 13.68 |
PBIT Margin (%) | 11.02 | 12.38 | 11.28 |
PBT Margin (%) | 8.50 | 1.12 | -2.99 |
Net PROFIT Margin (%) | 7.98 | 9.21 | 8.31 |
Return On Networth / Equity (%) | 12.69 | 13.63 | 10.69 |
Return On Networth /Employed (%) | 16.79 | 18.03 | 14.22 |
Return On Assets (%) | 12.13 | 13.45 | 10.47 |
Total Debt / Equity (X) | 0.04 | 0.01 | 0.01 |
Asset Turnover Ratio (%) | 1.52 | 1.46 | 1.26 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 14.71 |
PBIT Margin (%) | 11.02 |
PBT Margin (%) | 8.50 |
Net PROFIT Margin (%) | 7.98 |
Return On Networth / Equity (%) | 12.69 |
Return On Networth /Employed (%) | 16.79 |
Return On Assets (%) | 12.13 |
Total Debt / Equity (X) | 0.04 |
Asset Turnover Ratio (%) | 1.52 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 225.51 | 179.05 | 110.38 |
Total Current Assets Annual | 525.13 | 431.24 | 353.54 |
Non Current Assets Annual | 235.32 | 194.92 | 175.47 |
Total Shareholders Funds Annual | 505.79 | 450.29 | 402.67 |
Total Assets Annual | 760.45 | 626.16 | 529.01 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 225.51 |
Total Current Assets Annual | 525.13 |
Non Current Assets Annual | 235.32 |
Total Shareholders Funds Annual | 505.79 |
Total Assets Annual | 760.45 |
EPS (INR)
Expected
8.43
Reported
8.43
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%